The View Beyond LASIK: New Techs Further Propel Refractive Surgical Market
LASIK continues to hold a dominant share of the refractive surgical market but limitations in current technologies are stymying further growth. However, a tide of innovation refractive correction is coming in now, and over the next few years that will accelerate growth in this market and fully capitalize on this huge and yet undertapped opportunity known as presbyopia. This article discusses drivers and barriers in the refractive correction market and highlights three companies to look out for this space.
You may also be interested in...
Vagisil and BioFilm’s Astroglide “demonstrate very high levels of brand awareness, brand loyalty, and repeat purchase, and continue to attract new and younger consumers into the category,” firms say.
Nicotine mint lozenge approval for Perrigo; Lightbody for digital vision health; PLT has broad-spectrum immune health ingredient; Souvenaid for stronger synapses; Kinesiology tape for cellular oxygenation; Healthycell joint health and mobility gel; Nature’s Bounty Optimal Solutions hair, metabolism supplements; and Perricone extends vitamin c ester line.
Trade group contends FDA’s misuse of regulation prohibiting any substance studied or approved as a drug in US from being used as dietary ingredients undermines innovation in supplement industry and is detrimental to consumer choice and health.